Clinical trial
Estradiol for Neurocognitive Dysfunction After CABG
NCT00123539 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Estradiol for Neurocognitive Dysfunction After CABG
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2001
- Completion date
- August 31, 2005
- Enrollment
- 334
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.